ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
15 announcements with these filters
Krsnaa Diagnostics Ltd reported the successful passing of a special resolution via postal ballot approving the issuance of up to 16,21,000 convertible warrants to promoters.
Krsnaa Diagnostics executed a 15-year concession agreement with the Punjab Government to develop and operate PET-CT diagnostic facilities at four government hospitals.
Krsnaa Diagnostics received tax appellate orders for AY 2017-24 with aggregate disputed demands of ₹62.69 Crore. The company plans to file further appeals.
Krsnaa Diagnostics has filed its Business Responsibility and Sustainability Report for the financial year 2025-26 as required by regulatory listing obligations.
Krsnaa Diagnostics Limited has submitted the notice of its 16th Annual General Meeting, scheduled for September 28, 2026, along with the Annual Report for 2025-26.
Krsnaa Diagnostics issued a corrigendum to its Postal Ballot notice, providing additional disclosures regarding the proposed preferential issue of share warrants to promoters.
Krsnaa Diagnostics received an income tax rectification order for AY 2022-23, resulting in an additional demand of Rs. 12.10 Crore. The company intends to appeal.
Krsnaa Diagnostics will hold a postal ballot to seek shareholder approval for a preferential issue of convertible warrants totaling ₹91.75 Crore.
Krsnaa Diagnostics will seek shareholder approval via postal ballot to issue 16.21 lakh warrants to promoters at Rs. 566 per warrant, aggregating Rs. 91.75 Crore.
Krsnaa reported 22% revenue growth but suffered margin compression due to heavy front-ended costs for the Rajasthan project. Management pivots to 'long-term value' to deflect from current EBITDA and PAT dips.
Krsnaa Diagnostics reported 22% revenue growth in Q1 FY27, driven by expanding retail business and PPP project scaling, despite margin pressure from Rajasthan operationalization.
Krsnaa Diagnostics reported Q1 FY2027 revenue of ₹235.5 Crore, up 22% YoY. The Board also approved a preferential warrant issue for the Promoter Group.
Krsnaa Diagnostics Ltd reported revenue from operations of ₹235.5 Cr (+22.0% YoY) and net profit of ₹16.6 Cr (-19.0% YoY) for Q1 FY27.
Krsnaa Diagnostics Limited announced a board meeting scheduled for August 13, 2026, to discuss financial results for the quarter ending June 30, 2026, and fundraising proposals.
Krsnaa Diagnostics entered a PPP agreement with the Himachal Pradesh government to operate CT scan facilities at 34 health institutions, expanding from its previous 12 locations.